Probióticos como uma estratégia para o controle do colesterol: uma revisão
DOI:
https://doi.org/10.34119/bjhrv9n3-062Keywords:
colesterol sérico, hipercolesterolemia, probióticos, metabolismo lipídico, microbiota intestinalAbstract
A ingestão regular de microrganismos probióticos tem sido investigada como uma estratégia complementar para a modulação do perfil lipídico e redução do risco de doenças associadas. Os mecanismos de ação propostos incluem a desconjugação de sais biliares e a incorporação do colesterol pelas membranas bacterianas. Esta revisão integrativa analisou evidências sobre os efeitos de diferentes cepas probióticas no perfil lipídico. Os estudos avaliados demonstraram que determinadas cepas podem promover reduções significativas no colesterol sérico, sugerindo benefícios potenciais para o controle da hipercolesterolemia. Assim, os probióticos representam uma estratégia promissora, podendo ser usados como um adjuvante no controle da dislipidemia, embora sejam necessários estudos clínicos de maior duração e que levem em consideração a administração concomitante de medicamentos, para consolidar as recomendações terapêuticas específicas.
References
ABENAVOLI, L. et al. Gut Microbiota and Obesity: a role for probiotics. Nutrients, [S.L.], v. 11, n. 11, p. 2690-2709, 7 nov. 2019. MDPI AG. http://dx.doi.org/10.3390/nu11112690.
AFSHIN, A. et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, [s. l.], v. 393, n. 10184, p. 1958–1972, 2019. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S0140673619300418.
AGOLINO, G. et al. Bile salt hydrolase: the complexity behind its mechanism in relation to lowering-cholesterol lactobacilli probiotics. Journal Of Functional Foods, [S.L.], v. 120, p. 106357, set. 2024. Elsevier BV. http://dx.doi.org/10.1016/j.jff.2024.106357.
ALBERS, J. J. et al. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial. Atherosclerosis, [S.L.], v. 251, p. 454-459, ago. 2016. Elsevier BV. http://dx.doi.org/10.1016/j.atherosclerosis.2016.06.019.
AYYASH, M. M. et al. Invited review: characterization of new probiotics from dairy and nondairy products⠴insights into acid tolerance, bile metabolism and tolerance, and adhesion capability. Journal Of Dairy Science, [S.L.], v. 104, n. 8, p. 8363-8379, ago. 2021. American Dairy Science Association. http://dx.doi.org/10.3168/jds.2021-20398.
BASAK, A. Oral and Non-Oral Cholesterol-Lowering Drugs with PCSK9 and Other Biomolecules as Targets: Present Status and Future Prospects. Biomolecules, [s. l.], v. 15, n. 4, p. 468, 2025. Disponível em: https://www.mdpi.com/2218-273X/15/4/468.
BRASIL. Ministério da Saúde. Cenário das doenças crônicas não transmissíveis. 2023. Disponível em: <https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/vigitel/fact-sheet-cenario-das-doencas-cronicas-nao-transmissiveis-vigitel>. Acesso em: 11 out. 2025.
BULUT, S.; KABARAN, S. Effects of probiotic supplementation on blood lipids ın hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial. Nutrición Hospitalaria, [S.L.], p. 326-344, 2025. ARAN Ediciones. http://dx.doi.org/10.20960/nh.05563.
CAPONIO, G. R. et al. Regulation of Cholesterol Metabolism by Bioactive Components of Soy Proteins: novel translational evidence. International Journal Of Molecular Sciences, [S.L.], v. 22, n. 1, p. 227, 28 dez. 2020. MDPI AG. http://dx.doi.org/10.3390/ijms22010227.
CESENA, F. H. Y. et al. Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose–2025. Arq Bras Cardiol, v. 122, n. 9, p. e20250640, 2025.
CHANDRASEKARAN, P.; WEISKIRCHEN, S.; WEISKIRCHEN, R. Effects of Probiotics on Gut Microbiota: An Overview. International Journal of Molecular Sciences, [s. l.], v. 25, n. 11, p. 6022, 2024. Disponível em: https://www.mdpi.com/1422-0067/25/11/6022.
CHIU, H. F. et al. Efficacy of Probiotic Milk Formula on Blood Lipid and Intestinal Function in Mild Hypercholesterolemic Volunteers: a placebo-control, randomized clinical trial. Probiotics And Antimicrobial Proteins, [S.L.], v. 13, n. 3, p. 624-632, 6 jan. 2021. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s12602-020-09728-6.
FARWELL, W. R. et al. Non–High-Density Lipoprotein Cholesterol Versus Low-Density Lipoprotein Cholesterol as a Risk Factor for a First Nonfatal Myocardial Infarction. The American Journal Of Cardiology, [S.L.], v. 96, n. 8, p. 1129-1134, out. 2005. Elsevier BV. http://dx.doi.org/10.1016/j.amjcard.2005.06.044.
FEINGOLD, K. R. Cholesterol Lowering Drugs. [S. l.: s. n.], 2000. Disponível em: http://www.ncbi.nlm.nih.gov/pubmed/18841147.
FIGUEIREDO, A. E. B.; CECCON, R. F.; FIGUEIREDO, J. H. C. Doenças crônicas não transmissíveis e suas implicações na vida de idosos dependentes. Ciência & Saúde Coletiva, [S.L.], v. 26, n. 1, p. 77-88, jan. 2021. FapUNIFESP (SciELO). http://dx.doi.org/10.1590/1413-81232020261.33882020.
FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS (FAO); WORD HEALTH ORGANIZATION (WHO). Report of a Joint FAO/WHO Working Group on Drafiting Guidelines for the Evaluation of Probiotics in Food. 2002. Disponível em: <https://www.fao.org/3/a0512e/a0512e.pdf>. Acesso em: 2 nov. 2025.
FRAPPIER, M. et al. Screening and Characterization of Some Lactobacillaceae for Detection of Cholesterol-Lowering Activities. Probiotics And Antimicrobial Proteins, [S.L.], v. 14, n. 5, p. 873-883, 15 jun. 2022. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s12602-022-09959-9.
GU, S. et al. The role of probiotics in prevention and treatment of food allergy. Food Science And Human Wellness, [S.L.], v. 12, n. 3, p. 681-690, maio 2023. Tsinghua University Press. http://dx.doi.org/10.1016/j.fshw.2022.09.001.
GUERRERO-BONMATTY, R. et al. A Combination of Lactoplantibacillus plantarum Strains CECT7527, CECT7528, and CECT7529 Plus Monacolin K Reduces Blood Cholesterol: results from a randomized, double-blind, placebo-controlled study. Nutrients, [S.L.], v. 13, n. 4, p. 1206-1232, 6 abr. 2021. MDPI AG. http://dx.doi.org/10.3390/nu13041206.
GUO, J. et al. Cholesterol metabolism: physiological regulation and diseases. MedComm, [s. l.], v. 5, n. 2, 2024. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/mco2.476.
HALLORAN, K.; UNDERWOOD, M. Probiotic mechanisms of action. Early Human Development, [S.L.], v. 135, p. 58-65, ago. 2019. Elsevier BV. http://dx.doi.org/10.1016/j.earlhumdev.2019.05.010.
HILL, C. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews Gastroenterology & hepatology, 2014. Disponível em: <https://aura.abdn.ac.uk/bitstream/handle/2164/4189/nrgastro.2014.66.pdf?sequence=1> Acesso em: 6 nov.2025.
HOWE, V. et al. Cholesterol homeostasis: how do cells sense sterol excess?. Chemistry And Physics Of Lipids, [S.L.], v. 199, p. 170-178, set. 2016. Elsevier BV. http://dx.doi.org/10.1016/j.chemphyslip.2016.02.011.
HUBLER, Z. et al. Modulation of lanosterol synthase drives 24,25-epoxysterol synthesis and oligodendrocyte formation. Cell Chemical Biology, [s. l.], v. 28, n. 6, p. 866-875.e5, 2021. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S2451945621000519.
ISLAM, M. Z. et al. Newly characterized Lactiplantibacillus plantarum strains isolated from raw goat milk as probiotic cultures with potent cholesterol-lowering activity. Journal Of Agriculture And Food Research, [S.L.], v. 10, p. 100427, dez. 2022. Elsevier BV. http://dx.doi.org/10.1016/j.jafr.2022.100427.
JOSHI, T. J. et al. Functional metabolites of probiotic lactic acid bacteria in fermented dairy products. Food And Humanity, [S.L.], v. 3, p. 100341, dez. 2024. Elsevier BV. http://dx.doi.org/10.1016/j.foohum.2024.100341.
KHONGRUM, J. et al. Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: a randomized, double-blind, placebo-controlled clinical trial. Nutrients, [S.L.], v. 15, n. 3, p. 661, 28 jan. 2023. MDPI AG. http://dx.doi.org/10.3390/nu15030661.
KORCZ, E.; KERÉNYI, Z.; VARGA, L. Dietary fibers, prebiotics, and exopolysaccharides produced by lactic acid bacteria: potential health benefits with special regard to cholesterol-lowering effects. Food & Function, [s. l.], v. 9, n. 6, p. 3057–3068, 2018. Disponível em: https://xlink.rsc.org/?DOI=C8FO00118A.
LEE, H-C.; AKHMEDOV, A.; CHEN, C-H. Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: implications for disease progression and mechanistic insights. Frontiers In Cardiovascular Medicine, [S.L.], v. 9, p. 316-329, 4 out. 2022. Frontiers Media SA. http://dx.doi.org/10.3389/fcvm.2022.993633.
LIANG, XI. et al. Study on intestinal survival and cholesterol metabolism of probiotics. LWT, [S.L.], v. 124, p. 109132, abr. 2020. Elsevier BV. http://dx.doi.org/10.1016/j.lwt.2020.109132.
LUO, J.; YANG, H; SONG, B-L. Mechanisms and regulation of cholesterol homeostasis. Nature Reviews Molecular Cell Biology, [S.L.], v. 21, n. 4, p. 225-245, 17 dez. 2019. Springer Science and Business Media LLC. http://dx.doi.org/10.1038/s41580-019-0190-7.
LYE, H. S. et al. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. International journal of molecular sciences, v. 10, n. 9, p. 3755-3775, 2009.
MARQUARDT, D. et al. Cholesterol's location in lipid bilayers. Chemistry And Physics Of Lipids, [S.L.], v. 199, p. 17-25, set. 2016. Elsevier BV. http://dx.doi.org/10.1016/j.chemphyslip.2016.04.001.
MATSUBARA, V. H. et al. Probiotic Bifidobacteria in Managing Periodontal Disease: a systematic review. International Dental Journal, [S.L.], v. 73, n. 1, p. 11-20, fev. 2023. Elsevier BV. http://dx.doi.org/10.1016/j.identj.2022.11.018.
MCFARLAND, L. V.; EVANS, C. T.; GOLDSTEIN, E. J. C. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front. Med. (Lausanne), v. 5, p. 124, 7 May 2018. https://doi.org/10.3389/fmed.2018.00124.
MCFARLAND, L. V.; KARAKAN, T.; KARATAS, A. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. EClinicalMedicine, v. 41, 2021.
MITSCHE, M. A. et al. Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways. eLife, [s. l.], v. 4, 2015. Disponível em: https://elifesciences.org/articles/07999.
MOLUDI, J. et al. Interactive Effect of Probiotics Supplementation and Weight Loss Diet on Metabolic Syndrome Features in Patients With Coronary Artery Diseases: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. American Journal of Lifestyle Medicine, [s. l.], v. 15, n. 6, p. 653–663, 2021. Disponível em: https://journals.sagepub.com/doi/10.1177/1559827619843833.
MORA-VILLALOBOS, J. A. et al. Multi-Product Lactic Acid Bacteria Fermentations: a review. Fermentation, [S.L.], v. 6, n. 1, p. 23-44, 10 fev. 2020. MDPI AG. http://dx.doi.org/10.3390/fermentation6010023.
MULLAN, W.M.A. STARTER CULTURES | Importance of Selected Genera. Encyclopedia Of Food Microbiology, [S.L.], p. 515-521, 2014. Elsevier. http://dx.doi.org/10.1016/b978-0-12-384730-0.00321-9.
MUÑOZ, R.; MORENO-ARRIBAS, M. V.; RIVAS, B. L. Lactic Acid Bacteria. Molecular Wine Microbiology, [S.L.], p. 191-226, 2011. Elsevier. http://dx.doi.org/10.1016/b978-0-12-375021-1.10008-6.
NITHYA, A. et al. Probiotic potential of fermented foods and their role in non-communicable diseases management: an understanding through recent clinical evidences. Food Chemistry Advances, [S.L.], v. 3, p. 100381, dez. 2023. Elsevier BV. http://dx.doi.org/10.1016/j.focha.2023.100381.
NUANKHAM, K. et al. Impact of Lactocaseibacillus (Lactobacillus) paracasei sup. paracasei TISTR 2593 Probiotic Supplementation on the Gut Microbiome of Hypercholesterolemia Patients: a randomized controlled trial. Nutrients, [S.L.], v. 16, n. 17, p. 2916-2934, 1 set. 2024. MDPI AG. http://dx.doi.org/10.3390/nu16172916.
PATIAL, S. et al. Atherosclerosis: progression, risk factors, diagnosis, treatment, probiotics and synbiotics as a new prophylactic hope. The Microbe, [S.L.], v. 5, p. 212-231, dez. 2024. Elsevier BV. http://dx.doi.org/10.1016/j.microb.2024.100212.
PEREIRA, G. V. M. et al. How to select a probiotic? A review and update of methods and criteria. Biotechnology Advances, [S.L.], v. 36, n. 8, p. 2060-2076, dez. 2018. Elsevier BV. http://dx.doi.org/10.1016/j.biotechadv.2018.09.003.
PSOMAS, E. I. et al. Assimilation of cholesterol by yeast strains isolated from infant feces and Feta cheese. Journal of dairy science, v. 86, n. 11, p. 3416-3422, 2003.
PUJOL, M. C. Mecanismos básicos. Absorción y excreción de colesterol y otros esteroles. Clínica e Investigación En Arteriosclerosis, [S.L.], v. 26, n. 1, p. 41-47, jan. 2014. Elsevier BV. http://dx.doi.org/10.1016/j.arteri.2013.10.008.
SHARIFI, M. et al. Polygenic Hypercholesterolemia and Cardiovascular Disease Risk. Humphries SE. Curr Cardiol Rep. [S.L], v. 21, n.6, p. 310-320, abr. 2019. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s11886-019-1130-z.
SHOKRYAZDAN, P. et al. Probiotics: from isolation to application. Journal Of The American College Of Nutrition, [S.L.], v. 36, n. 8, p. 666-676, 22 set. 2017. Informa UK Limited. http://dx.doi.org/10.1080/07315724.2017.1337529.
SOHN, M. et al. Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: a randomized, double-blind controlled clinical trial. Frontiers In Endocrinology, [S.L.], v. 12, p. 327-345, 19 jan. 2022. Frontiers Media SA. http://dx.doi.org/10.3389/fendo.2021.790046.
SONG, X. et al. Role of intestinal probiotics in the modulation of lipid metabolism: implications for therapeutic treatments. Food Science And Human Wellness, [S.L.], v. 12, n. 5, p. 1439-1449, set. 2023. Tsinghua University Press. http://dx.doi.org/10.1016/j.fshw.2023.02.005.
TAN, S. T.; TAN, Seok Shin; TAN, Chin Xuan. Soy protein, bioactive peptides, and isoflavones: a review of their safety and health benefits. Pharmanutrition, [S.L.], v. 25, p. 100352, set. 2023. Elsevier BV. http://dx.doi.org/10.1016/j.phanu.2023.100352.
TIAN, Y. et al. Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial. Medicine, [s. l.], v. 103, n. 21, p. e37883, 2024. Disponível em: https://journals.lww.com/10.1097/MD.0000000000037883.
VOURAKIS, M.; MAYER, G.; ROUSSEAU, G. The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis. International Journal of Molecular Sciences, [s. l.], v. 22, n. 15, p. 8074, 2021. Disponível em: https://www.mdpi.com/1422-0067/22/15/8074.
WANG, C. et al. The effect of probiotic supplementation on lipid profiles in adults with overweight or obesity: A meta-analysis of randomized controlled trials. Journal of Functional Foods, [s. l.], v. 86, p. 104711, 2021. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S1756464621003601.
WHITTEMORE, R.; KNAFL, K. The integrative review: updated methodology. Journal Of Advanced Nursing, [S.L.], v. 52, n. 5, p. 546-553, 2 nov. 2005. Wiley. http://dx.doi.org/10.1111/j.1365-2648.2005.03621.x.
WIDODO, W. et al. Cholesterol Assimilation of Two Probiotic Strains of Lactobacillus casei used as Dairy Starter Cultures. Applied Food Biotechnology, [S.L.], v. 8, n. 2, p. 103-112, 16 mar. 2021. National Nutrition and Food Technology Research Institute. http://dx.doi.org/10.22037/afb.v8i2.30661.
WIECZOREK, E. et al. The Differential Effects of HDL Subpopulations on Lipoprotein Lipase (LPL)-Mediated VLDL Catabolism. Biomedicines, [S.L.], v. 9, n. 12, p. 1839, 5 dez. 2021. MDPI AG. http://dx.doi.org/10.3390/biomedicines9121839.
WORLD HEALTH ORGANIZATION - WHO. Reducing risks and detecting early to prevent and manage noncommunicable diseases. 2023. Disponível em: <https://cdn.who.int/media/docs/default-source/universal-health-coverage/who-uhl-technical-brief-ncds.pdf?sfvrsn=af5127e4_3&download=true>. Acesso em: 11 out. 2025.
WU, L-Y. et al. The role of probiotics in women's health: an update narrative review. Taiwanese Journal Of Obstetrics And Gynecology, [S.L.], v. 63, n. 1, p. 29-36, jan. 2024. Elsevier BV. http://dx.doi.org/10.1016/j.tjog.2023.09.018.
ZAFAR, H. et al. Lacticaseibacillus rhamnosus FM9 and Limosilactobacillus fermentum Y57 Are as Effective as Statins at Improving Blood Lipid Profile in High Cholesterol, High-Fat Diet Model in Male Wistar Rats. Nutrients, [S.L.], v. 14, n. 8, p. 1654-1669, 15 abr. 2022. MDPI AG. http://dx.doi.org/10.3390/nu14081654.
ZHAO, Y. et al. Structure-Specific Effects of Short-Chain Fatty Acids on Plasma Cholesterol Concentration in Male Syrian Hamsters. Journal of Agricultural and Food Chemistry, [s. l.], v. 65, n. 50, p. 10984–10992, 2017. Disponível em: https://pubs.acs.org/doi/10.1021/acs.jafc.7b04666.
ZIO, S. et al. Health interest of cholesterol and phytosterols and their contribution to one health approach: Review. Heliyon, [s. l.], v. 10, n. 21, p. e40132, 2024. Disponível em: https://linkinghub.elsevier.com/retrieve/pii/S2405844024161634.
